Scherm­afbeelding 2023 10 02 om 16.47.33

Sphere Fluidics expands Cyto-Mine capabilities to meet cGMP requirements for drug manufacture workflows

Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, has updated its flagship platform, Cyto-Mine, enabling it to be compliant with current Good Manufacturing Practice (cGMP) regulations enforced by the US FDA. By meeting these requirements, the company now provides a solution to increase efficiency and productivity of cell […]

CN Bio Tomasz Kostrzewski

CN Bio and LifeNet Health LifeSciences partner to supply validated primary human cells for micro-physiological systems

CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), and LifeNet Health LifeSciences, a non-profit, global leader in human research solutions, will collaborate to supply validated primary human cells for use with CN Bio’s PhysioMimix OOC range of MPS. Under the agreement, LifeNet Health’s high-quality, MPS validated, hepatic […]

ISSCR check list

ISSCR introduces checklist to promote global best practices for human stem cell research

ISSCR introduces checklist to promote global best practices for human stem cell research Recommendations from the Standards for Human Stem Cell Use in Research [1],  published in June by the International Society for Stem Cell Research (ISSCR), include a publishing “checklist” that is now being used by laboratory scientists and implemented in the review process […]

Broken String Felix Dobbs

Broken String Biosciences Closes $15M Series A Funding Round

Broken String Biosciences, a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, has closed a US$15 million Series A investment round, co-led by Illumina Ventures and Mérieux Equity Partners, with contributions from HERAN Partners, and existing investors Tencent and Dieter von Holtzbrinck Ventures […]

Astrea Bio Chris Brown

Astrea Bio expands US manufacturing and warehousing capacity to cater to growing demand

Astrea Bioseparations will expand its manufacturing and warehousing capabilities in the US. The increased capacity reflects growing demand for the Company’s chromatography solutions in North American markets.

TherageniX Dr James Dixon

TherageniX awarded £995K grant to develop powdered gene therapy for bone regeneration

TherageniX, a University of Nottingham spin out pioneering a dry powder gene therapy formulation for bone graft augmentation, and its collaborator, the University of Nottingham, have been awarded a £995,000 grant from Innovate UK, the UK’s innovation agency. The funding will support the development of the company’s gene therapy in a powder, a non-viral gene delivery […]

Hayden Jeffreys

MolGen appoints Hayden Jeffreys as Global Vice President of Sales & Marketing

MolGen, a global solutions provider of innovative DNA/RNA extraction and lab automation, has appointed Hayden Jeffreys as Global Vice President of Sales & Marketing.

shutterstock 1727098729

Agilent Technologies sells Resolution Bioscience to Exact Sciences

Agilent Technologies will sell Resolution Bioscience to Exact Sciences, a leading provider of cancer screening and diagnostic tests. Financial terms of the agreement were not disclosed. Resolution Bioscience develops and commercializes next-generation sequencing-based precision oncology solutions. Agilent acquired the company in 2021.

SMi Systems

SMi Systems secures UK patent for breakthrough single-molecule imaging technology

SMi Systems has secured a patent from the UK Intellectual Property Office (IPO) for the single-molecule imaging technologies that underpin its super-resolution multi-omic platform. The patented technology consists of highly specialised optics that allow SMi to view single molecules at unprecedented resolution. When combined with the company’s uniquely designed consumables and deep learning techniques, the […]

shutterstock 1670731600

SSI Strategy and NDA Group combine to form best-in-class global life sciences consultancy

SSI Strategy will acquire NDA Group, a leading regulatory affairs and drug development consultancy. Financial terms of the transaction were not disclosed.